Get Healthy!

An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment.

The drug's maker, Novartis Pharmaceuticals Corp., has said it can't keep up with demand for the medication, known as Pluvicto.

Doctors have had to reschedule some patients who were due to start their first doses of the treatment. Mean...

Does having an enlarged prostate doom you to prostate cancer?

Far from it, a new study suggests.

Also called benign prostatic hyperplasia (BPH), the condition may actually provide some protection for men from developing prostate cancer, researchers report.

"Men are often anxious about prostate cancer, as it is the second most common cancer in men, with some worrying BPH increa...